General Information of Drug (ID: DMTURZ6)

Drug Name
YS110 mAb clone Drug Info
Synonyms YS110
Indication
Disease Entry ICD 11 Status REF
Middle East Respiratory Syndrome (MERS) 1D64 Investigative [1]
Therapeutic Class
Antiviral Agents
Cross-matching ID
TTD Drug ID
DMTURZ6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Linagliptin DMWFJTR Non-insulin dependent diabetes 5A11 Approved [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
HUMAN dipeptidyl peptidase 4 (DPP-4) TTF928K DPP4_HUMAN Blocker [1]

References

1 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.
2 DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19 Diabetes Metab Res Rev. 2020 Apr 26.